THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- SoniVie Inc.
- Study ID
- NCT06559891
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- TIVUS™ Renal Denervation System — DEVICERenal artery catheterization procedure used to denervate the renal sympathetic nerves in the perivascular space using ultrasound energy.
- Sham — OTHERFor those subjects randomized to the sham control, the angiogram will serve as the sham procedure.
Study Details
The primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncontrolled hypertension (HTN) receiving 0 - 2 anti-hypertensive drugs of different classes in whom the anti-hypertensive medications will be stopped for a 4-week wash-out period before RDN/Sham procedure and during 2 months after procedure. 2. subjects with controlled hypertension receiving 1 - 2 anti-hypertensive drugs of different classes and who accept to be off-medications for a 4-week wash-out period before RDN/Sham procedure and 2 months after the procedure
Key Dates
- Start date
- Oct 3, 2024
- Status verified
- May 2026
- Primary completion
- Mar 31, 2027
- Completion
- Aug 15, 2028
Study Design
- Enrollment
- 261 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: TIVUS™ Renal Denervation SystemFollowing angiogram, subjects found anatomically eligible and randomized to the renal denervation arm will be treated with the TIVUS™ Renal Denervation System.
- Sham Comparator: ShamFor those subjects randomized to the sham control, the angiogram will serve as the sham procedure.
Primary Outcome Measure
Reduction in average daytime ambulatory systolic BP [ Time Frame: From baseline to 2 months post-procedure ]
Central Contacts
- Lisa Melchior651-324-4931
- Janelle Noble612-598-4368
Locations (33)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cardiology, PC | Birmingham | Alabama | 35211 | Susan DeRamus Farrell O Mendelsohn (PRINCIPAL_INVESTIGATOR) |
| Honor Health Research Institue | Scottsdale | Arizona | 85258 | Taral Patel, MD |
| St. Bernard's Medical Center | Jonesboro | Arkansas | 72401 | Maximilliano Arroyo, MD Sasha Potter mailto:[email protected] |
| Arkansas Heart Hospital | Little Rock | Arkansas | 72211 | Andre Paixao, MD Leybi Ramirez-Kelly, PhD |
| Cedar-Sinai Medical Center | Los Angeles | California | 90048 | Florian Radar, M.D. Maria Thottam |
| Stanford University | Palo Alto | California | 94305 | David Lee, MD |
| Bridgeport | Bridgeport | Connecticut | 06610 | Edward Touhy, MD |
| Ascension- Sacred Heart | Pensecola | Florida | 32504 | Rohit Amin, MD |
| University of South Florida | Tampa | Florida | 33606 | Fadi Matar, MD |
| Ascension Alexian Brothers | Elk Grove Village | Illinois | 60007 | Alexander Fraley, M.D. (PRINCIPAL_INVESTIGATOR) |
| Southern Illinois University, School of Medicine | Springfield | Illinois | 62794 | John Flack, MD |
| St. John's Prairie Heart | Springfield | Illinois | 62710 | Avinash Murthy, MD |
| Cardiovascular Institute of the South | Houma | Louisiana | 70360 | Craig Walker |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | James Jenkins, MD |
| Henry Ford Hospital | Detroit | Michigan | 48202 | Herbert D Aronow, MD Michelle Butcher |
| Henry Ford Providence Hospital | Southfield | Michigan | 48075 | Shukri David, MD Yulia Abidov |
| Gulfport Memorial Hospital | Gulfport | Mississippi | 39501 | Wayne Latack, MD |
| Jackson Heart | Jackson | Mississippi | 39216 | Grey Bennett, MD |
| St Lukes Hospital | Kansas City | Missouri | 64131 | Steven B Laster, MD |
| Renown Regional Medical Center | Reno | Nevada | 89502 | Michael Bloch, MD |
| Virtua Health | Camden | New Jersey | 08103 | Kintur Sanghvi, MD |
| Jersey Shore University Medical Center | Neptune City | New Jersey | 07753 | Matthew Saybolt, MD |
| St. Joseph | Liverpool | New York | 13088 | Ayman Iskander, MD |
| Nyph/Cumc | New York | New York | 10032 | Ari Mintz, MD |
| NC Heart and Vascular | Raleigh | North Carolina | 27607 | James Pierre-Louis James Zidar (PRINCIPAL_INVESTIGATOR) |
| Ascension St. John Clinical Research Institute | Bartlesville | Oklahoma | 74006 | Anderson Mehrle, MD |
| Lancaster General Health | Lancaster | Pennsylvania | 17603 | Rupal Dumasia, MD |
| Penn Medicine | Philadelphia | Pennsylvania | 19104 | Deborah Cohen, MD |
| MUSC | Mt. Pleasant | South Carolina | 29464 | Thomas Todoran, MD, MS |
| Medical City | Fort Worth | Texas | 76104 | Ali Farhan, M.D. |
| Houston Medical Center | Houston | Texas | 77004 | Arnav Kumar, M.D. |
| St Marks Hospital | Salt Lake City | Utah | 37027 | Vamsee Yaganti, M.D. |
| Chippenham Hospital | Richmond | Virginia | 23225 | Nayef Abouzaki, MD |
Find similar trials in Birmingham, AL
Related Studies
- Effect of Electro-Acupuncture on Blood PressureRecruiting · University of California, Irvine · Irvine, California
- : Vascular Function in Health and DiseasePHASE1 · Recruiting · Russell Richardson · Salt Lake City, Utah
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Blood Pressure Slopes and Ultrafiltration in Hemodialysis PatientsRecruiting · VA Office of Research and Development · Dallas, Texas